Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide
MPC, RHHBF, PSX, DINO, NVO, AZNCF, VLO, LLY, PFE, BA
BNTX
LIN, UBER
SQ
F, EVRG, KHC, LVS, FTV, O, WBA, DOC, CTSH, LPLA, SQ, RPRX, GM, EL, BEN, OTIS, CCL, DOW, ROK, MGM, APA, LKQ, SSNC, ZM, ALB, HES, ALLE, WTRG, CNH, MRNA, DAY
Karen Andersen
Sector Strategist